Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concizumab Phase 3 study in males (Japan)
jRCT2080224958Phase 3Recruiting
- Start
- Nov 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3 trial of concizumab. Started Nov 2019; status: recruiting.
02
Drugs
concizumab
Beyond the preview
Go deeper on jRCT2080224958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224958.